Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biohaven (BHVN) Net Income towards Common Stockholders (2021 - 2026)

Biohaven has reported Net Income towards Common Stockholders over the past 6 years, most recently at -$130.5 million for Q1 2026.

  • Quarterly results put Net Income towards Common Stockholders at -$130.5 million for Q1 2026, up 41.12% from a year ago — trailing twelve months through Mar 2026 was -$647.7 million (up 27.11% YoY), and the annual figure for FY2025 was -$738.8 million, up 12.71%.
  • Net Income towards Common Stockholders reached -$130.5 million in Q1 2026 per BHVN's latest filing, up from -$145.6 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$68.9 million in Q3 2022 and bottomed at -$319.8 million in Q2 2024.
  • Median Net Income towards Common Stockholders over the past 5 years was -$160.3 million (2024), compared with a mean of -$158.5 million.
  • The largest annual shift saw Net Income towards Common Stockholders crashed 287.59% in 2022 before it soared 55.56% in 2023.
  • Over 5 years, Net Income towards Common Stockholders stood at -$201.1 million in 2022, then increased by 28.02% to -$144.8 million in 2023, then dropped by 29.07% to -$186.8 million in 2024, then rose by 22.1% to -$145.6 million in 2025, then rose by 10.32% to -$130.5 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for BHVN at -$130.5 million in Q1 2026, -$145.6 million in Q4 2025, and -$173.4 million in Q3 2025.